HK/China Healthcare Analyst (ex-Fosun Pharma)

Xinyao (Criss) Wang

Over 15 years' experience in both finance and healthcare, covering clinic operations, investment and equity research in both China and overseas.

China Healthcare Weekly (Aug11)-Anti-Corruption Update, Increase A-Share Shareholder Return, CanSino

China Healthcare Weekly (Aug.18) - TCM Formula Granules VBP, Global Financing Rebound, CR Sanjiu

Pre-IPO BrainAurora Medical Technology - The Outlook Is Highly Uncertain

Hygeia Healthcare (6078.HK) - Profits Fell Short of Expectations, but the Outlook Remains Positive

Hygeia Healthcare Placement (6078.HK)- The Prospect Is More Certain After the Policy Risk Is Removed

Hygeia Healthcare Group (6078.HK) 22H1 - The Logic and the Outlook

Battle Lines Drawn As BABA Builds Out First/Last-Mile Capacity; But Who Will Fund 75+ Bn CNY CapEx?

Equity Bottom-Up

Hygeia Healthcare Group / Equity Bottom-Up

<ul>
<li>Based on endogenous development and external M&amp;A, the outlook of Hygeia is full of imagination. Hygeia also start to expand business in northwest region of China by acquiring Chang'an Hospital.</li>
<li>If public hospitals have a role in “guiding patients” to Hygeia, anti-corruption campaign would affect Hygeia's future performance, which is a significant uncertainty that could also shake its investment logic.</li>
<li>There may be short-term chaos. It remains to be seen whether performance can sustain growth of around 30%. The 23H2 revenue growth would be an important guidance for Hygeia's outlook.</li>
</ul>


Based on endogenous development and external M&amp;A, the outlook of Hygeia is full of imagination. Hygeia also start to expand business in northwest region of China by acquiring Chang'an Hospital.
If public hospitals have a role in “guiding patients” to Hygeia, anti-corruption campaign would affect Hygeia's future performance, which is a significant uncertainty that could also shake its investment logic.
There may be short-term chaos. It remains to be seen whether performance can sustain growth of around 30%. The 23H2 revenue growth would be an important guidance for Hygeia's outlook.


Hygeia Healthcare Group (6078.HK) - The Crack in the Egg